Details Basic Details Approval Date Friday, December 8, 2017 Health Outcome(s) cataracts, glaucoma, nasal septal perforation Regulatory Link(s) (2) ARIA Memo FDA Approval Package Link(s) Sentinel Drug Study: Sinuva (Mometasone Furoate) & Cataracts, Diminished Visual Acuity, Glaucoma, and Nasal Septal Perforation